Skip to main content

Table 2 Characteristics of MRSA strains tested in this study

From: ST9 MRSA strains carrying a variant of type IX SCCmec identified in the Thai community

Isolate no.a

Origin of specimen

Disease

Minimum inhibitory concentrationb(μg/mL)

 

ccr gene type

mecgene complex class

meroperon

copA

agrtype

Coagulase type

spatype

MLST (ST)

Van

Cefa

Oxa

Cefox

Tetra

Erythro

Ofx

        

Isolates from outpatients (n = 14)

O-1

Pus Left thigh (Human)

Accident, infected wound

2

> 64

> 64

> 64

32

> 64

> 64

ccrA3B3

A

-

-

I

IV

t037

ST239

O-2

Pus Leftfoot (Human)

Atopic dermatitis

1

32

32

32

> 64

> 64

> 64

ccrA1B1

C2

-

+

II

XIc

t337

ST9

O-3

Wound (Human)

Electrical burn

2

> 64

> 64

> 64

64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t233

ST239

O-4

Pus (Human)

NA

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-5

Pus (Human)

Infected wound

1

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

+

I

IV

t037

NT

O-6

Tracheal suction (Human)

NA

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

ST239

O-7

Sputum (Human)

Pulmonary TB

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-8

Wound (Human)

Accident, head injury

2

> 64

> 64

> 64

64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-9

Wound (Human)

Accident, infected wound

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-10

Pus Left cheek (Human)

NA

1

> 64

> 64

> 64

64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-11

Pus scalp (Human)

Chronic scalp impetigo

2

> 64

> 64

> 64

64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-12

Tissue (Human)

Gas gangrene

2

> 64

> 64

> 64

32

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-13

Sputum (Human)

NA

2

> 64

> 64

> 64

64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

O-14

Pus Lt thigh (Human)

Accident, infected wound

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

Isolates from in patients (n = 5)

I-1

Blood (Human)

NA

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3

A

+

-

I

IV

t037

NT

I-2

Blood (Human)

NA

1

> 64

> 64

> 64

> 64

16

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

NT

I-3

Blood (Human)

NA

1

> 64

> 64

> 64

8

> 64

> 64

ccrA3B3ccrC

A

+

+

I

IV

UDc

ST1429

I-4

Sputum (Human)

NA

2

> 64

> 64

> 64

> 64

> 64

> 64

ccrA3B3ccrC

A

+

-

I

IV

t037

ST239

I-5

Sputum (Human)

NA

2

> 64

> 64

> 64

32

> 64

> 64

ccrA3B3ccrC

A

-

-

I

IV

t037

ST239

An isolate from healthy worker (n = 1)

N-1

Nasal swab (Human)

colonize

1

> 64

64

32

64

1

> 64

ccrA1B1

C2

-

+

II

XIc

t337

ST9

An isolate from pig (n = 1)

P-1

Lung (pig)

pneumonia

1

> 64

> 64

64

> 64

64

> 64

ccrA1B1

C2

-

+

II

XIc

t044

ST9

  1. a O, outpatient; I, inpatient; N, nurse; P, pig; NA, information was not available.
  2. b Van, vancomycin; Cefa, cefazolin; Oxa, oxacillin; Cefox, cefoxitin; Tetra, tetracycline; Erythro, erythromycin; Ofx, ofloxacin.
  3. C ND,Undetermined; because no PCR product was amplified.